BB&T Investment Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.8M Buy
39,302
+2,869
+8% +$270K 0.64% 36
2017
Q3
$3.25M Buy
36,433
+4,690
+15% +$357K 0.65% 31
2017
Q2
$2.29M Buy
31,743
+10,813
+52% +$727K 0.57% 34
2017
Q1
$1.37M Buy
20,930
+4,857
+30% +$305K 0.54% 32
2016
Q4
$1.01M Buy
+16,073
New +$981K 0.74% 29

Other funds holding ABBV

BB&T Investment Services's ABBV Position: Q4 2017 in Review

BB&T Investment Services increased its AbbVie (ABBV) stake by 7.9% in Q4 2017, buying an estimated $270K and bringing the position to 39,302 shares worth $3.8M. The position accounts for 0.64% of the portfolio, ranked #36.

BB&T Investment Services first reported a position in ABBV in Q4 2016 and has held it in 5 quarters since. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • BB&T Investment Services held 39,302 shares of AbbVie worth $3.8M as of Q4 2017.
  • BB&T Investment Services bought 2,869 AbbVie shares in Q4 2017, an estimated $270K.
  • AbbVie made up 0.64% of BB&T Investment Services's portfolio in Q4 2017, its #36 holding.
  • BB&T Investment Services first reported a position in AbbVie in Q4 2016 and has held it in 5 quarters since.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.